BioVie Presents Data for NE3107 at 2023 International Congress of Parkinson's Disease and Movement Disorders Seite 1
28.08.2023 - New preclinical data characterizing NE3107 mechanism of action featured in oral presentationPhamacokinetic data from Phase 2a study supports potential co-administration of NE3107 with carbidopa/levodopaSeparate analysis of Phase 2a study data shows ... Seite 1
Source: wallstreet-online.de